These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18433501)

  • 1. Androgenic dependence of exophytic tumor growth in a transgenic mouse model of bladder cancer: a role for thrombospondin-1.
    Johnson AM; O'Connell MJ; Miyamoto H; Huang J; Yao JL; Messing EM; Reeder JE
    BMC Urol; 2008 Apr; 8():7. PubMed ID: 18433501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased bladder cancer growth in parous mice.
    Johnson AM; O'Connell MJ; Messing EM; Reeder JE
    Urology; 2008 Sep; 72(3):470-3. PubMed ID: 18533230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection and measurement of urothelial tumors in mice.
    Johnson AM; Conover DL; Huang J; Messing EM; Ning R; O'Connell MJ; Rossi MA; Sun TT; Wood RW; Wu XR; Reeder JE
    Urology; 2006 Jun; 67(6):1309-14. PubMed ID: 16765196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.
    Madka V; Zhang Y; Li Q; Mohammed A; Sindhwani P; Lightfoot S; Wu XR; Kopelovich L; Rao CV
    Neoplasia; 2013 Aug; 15(8):966-74. PubMed ID: 23908596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.
    Zhang Z; Xu Q; Huang X; Yang J; Xu Y; Zhang G
    Int J Clin Exp Pathol; 2015; 8(9):10283-93. PubMed ID: 26617736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice.
    Madka V; Mohammed A; Li Q; Zhang Y; Patlolla JM; Biddick L; Lightfoot S; Wu XR; Steele V; Kopelovich L; Rao CV
    Cancer Prev Res (Phila); 2014 Jul; 7(7):708-16. PubMed ID: 24795386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kava chalcone, flavokawain A, inhibits urothelial tumorigenesis in the UPII-SV40T transgenic mouse model.
    Liu Z; Xu X; Li X; Liu S; Simoneau AR; He F; Wu XR; Zi X
    Cancer Prev Res (Phila); 2013 Dec; 6(12):1365-75. PubMed ID: 24121102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen dependency of hepatocarcinogenesis in TGFalpha transgenic mice.
    Matsumoto T; Takagi H; Mori M
    Liver; 2000 Jun; 20(3):228-33. PubMed ID: 10902973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of bladder cancer development and progression by androgen receptor signals.
    Miyamoto H; Yang Z; Chen YT; Ishiguro H; Uemura H; Kubota Y; Nagashima Y; Chang YJ; Hu YC; Tsai MY; Yeh S; Messing EM; Chang C
    J Natl Cancer Inst; 2007 Apr; 99(7):558-68. PubMed ID: 17406000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
    Colombel M; Filleur S; Fournier P; Merle C; Guglielmi J; Courtin A; Degeorges A; Serre CM; Bouvier R; Clézardin P; Cabon F
    Cancer Res; 2005 Jan; 65(1):300-8. PubMed ID: 15665307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation.
    Fitchev PP; Wcislak SM; Lee C; Bergh A; Brendler CB; Stellmach VM; Crawford SE; Mavroudis CD; Cornwell ML; Doll JA
    Lab Invest; 2010 Jul; 90(7):1078-90. PubMed ID: 20458281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
    Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
    Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
    Johnson DT; Hooker E; Luong R; Yu EJ; He Y; Gonzalgo ML; Sun Z
    PLoS One; 2016; 11(2):e0148851. PubMed ID: 26862755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model.
    Cheng L; Zhang S; Sweeney CJ; Kao C; Gardner TA; Eble JN
    Anticancer Res; 2004; 24(4):2135-40. PubMed ID: 15330153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
    Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth.
    Cheng J; Huang H; Zhang ZT; Shapiro E; Pellicer A; Sun TT; Wu XR
    Cancer Res; 2002 Jul; 62(14):4157-63. PubMed ID: 12124355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
    Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
    Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen and fibroblast growth factor 8 (FGF8) downregulation of thrombospondin 1 (TSP1) in mouse breast cancer cells.
    Mattila MM; Tarkkonen KM; Seppänen JA; Ruohola JK; Valve EM; Härkönen PL
    Mol Cell Endocrinol; 2006 Jul; 253(1-2):36-43. PubMed ID: 16723184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
    Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
    Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin-induced decrease in prostate-specific antigen expression with no effect on tumor growth in the LNCaP model of human prostate cancer.
    Thalmann GN; Sikes RA; Chang SM; Johnston DA; von Eschenbach AC; Chung LW
    J Natl Cancer Inst; 1996 Jun; 88(12):794-801. PubMed ID: 8637045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.